Clover Biopharmaceuticals Is A Global Biotechnology Company Focused On Developing And Commercializing Innovative Vaccines To Enhance Health Worldwidefounded In June 2007 By Drliangthe Company Utilizes Its Proprietary Trimer Tag Technology Platform To Create Trimeric Proteins That Mimic Viral Structuresimproving Immune Responses Clover Has A Diverse Pipeline Of Vaccine Candidates Targeting Various Infectious Diseasesnotable Projects Include A Bivalent Rsv Vaccine Candidatescb 1019Which Has Shown Positive Clinical Resultsand A Covid 19 Vaccine With Ongoing Development For Next Generation Optionsthe Company Manages The Entire Lifecycle Of Vaccine Developmentfrom Research And Development To Manufacturing And Commercializationensuring Its Products Are Accessible To Populations Globally
